12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CAP-1002: Phase I/II ongoing

Capricor said a DSMB cleared continuation to the Phase II portion of the double-blind, placebo-controlled, U.S. Phase I/II ALLSTAR trial after CAP-1002 met...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >